+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Programmed Cell Death Protein"

Checkpoint Inhibitors Market Report 2025 - Product Thumbnail Image

Checkpoint Inhibitors Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Drugs for Immunotherapy Market Report 2025 - Product Thumbnail Image

Drugs for Immunotherapy Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Nasopharyngeal Carcinoma Treatment Market Report 2025 - Product Thumbnail Image

Nasopharyngeal Carcinoma Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Gastric Cancer Drugs Market Report 2025 - Product Thumbnail Image

Gastric Cancer Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Immuno-Oncology Drugs Market Report 2025 - Product Thumbnail Image

Immuno-Oncology Drugs Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Metastatic Cancer Drugs Market Report 2025 - Product Thumbnail Image

Metastatic Cancer Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Cancer Biological Therapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Biological Therapy - Global Strategic Business Report

  • Report
  • June 2025
  • 211 Pages
  • Global
From
From
Immuno-Oncology - Global Strategic Business Report - Product Thumbnail Image

Immuno-Oncology - Global Strategic Business Report

  • Report
  • June 2025
  • 224 Pages
  • Global
From
From
Cancer Immunotherapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Immunotherapy - Global Strategic Business Report

  • Report
  • June 2025
  • 93 Pages
  • Global
From
Urothelial Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Urothelial Cancer Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 93 Pages
  • Global
From
Immunotherapy Drugs - Global Strategic Business Report - Product Thumbnail Image

Immunotherapy Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 193 Pages
  • Global
From
Metastatic Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Metastatic Cancer Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 377 Pages
  • Global
From
From
From
Gastric Cancer - Global Strategic Business Report - Product Thumbnail Image

Gastric Cancer - Global Strategic Business Report

  • Report
  • June 2025
  • 582 Pages
  • Global
From
From
Oncolytic Virus Therapy - Global Strategic Business Report - Product Thumbnail Image

Oncolytic Virus Therapy - Global Strategic Business Report

  • Report
  • June 2025
  • 483 Pages
  • Global
From
Loading Indicator

Programmed Cell Death Protein (PDP) is a type of protein that plays a role in the regulation of cell death in the body. It is a key component of the body's natural defense against cancer, as it helps to prevent the growth and spread of cancerous cells. In oncology drugs, PDP is used to target and destroy cancer cells, while leaving healthy cells unharmed. PDP is also used to reduce the side effects of chemotherapy and radiation therapy, as well as to reduce the risk of recurrence of cancer. PDP is also used to reduce the risk of metastasis, or the spread of cancer to other parts of the body. PDP is a rapidly growing market, with many companies developing and marketing PDP-based drugs. Some of these companies include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. Show Less Read more